Xuyan Yang

1.0k citations
28 papers · 713 indexed · h-index 12
Topics
Systemic Lupus Erythematosus Research (8 papers)IL-33, ST2, and ILC Pathways (4 papers)Psoriasis: Treatment and Pathogenesis (4 papers)

In The Last Decade

Xuyan Yang

27 papers receiving 704 citations

Peers

Xuyan Yang
Comparison fields: 5 of 86
  • Immunology 359
  • Molecular Biology 274
  • Rheumatology 122
  • Epidemiology 67
  • Oncology 66
Replace Heonsik Choi with:
Heonsik Choi South Korea
Nora Müller Germany
Ei Wakamatsu Japan
Erwan Garo France
Isabelle Allaeys Canada
Ksanthi Kranidioti Greece
Ioannis Morianos Greece
Jason Douangpanya United States
Chaokui Wang China
Kelly A. Remedios United States
Xuyan Yang relative to Heonsik Choi South Korea Heonsik Choi's profile →
Citations per field
00.5×1.5×
Heonsik Choi · 1×
Citations per year

Countries citing papers authored by Xuyan Yang

Since Specialization
Citations

This map shows the geographic impact of Xuyan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuyan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuyan Yang more than expected).

Fields of papers citing papers by Xuyan Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuyan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuyan Yang. The network helps show where Xuyan Yang may publish in the future.

Co-authorship network of co-authors of Xuyan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xuyan Yang. A scholar is included among the top collaborators of Xuyan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuyan Yang. Xuyan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 12
3 3
4 1
5 1
6 15
7 3
8 19
9 5
10 101
11 5
12 250
13
Increased interleukin-22 levels in lupus nephritis and its associated with disease severity: a study in both patients and lupus-like mice model.
18
14 8
15 22
16 1
17 77
18 10
19 56
20 32

About Xuyan Yang

Xuyan Yang is a scholar working on Immunology, Immunology and Allergy and Rheumatology, having authored 28 papers that have together received 713 indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (8 papers), IL-33, ST2, and ILC Pathways (4 papers) and Psoriasis: Treatment and Pathogenesis (4 papers). The work is most often cited by research in Immunology (359 citations), Rheumatology (122 citations) and Biological Psychiatry (16 citations). Xuyan Yang has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Song Guo Zheng, Ting Xu, Sheng Chen, Danlu Jiang, Kailian Zhang, Weiwei Yu, Zhexu Chi, Xue Zhang, Yingliang Wu and Wenxin Li. Their work appears in journals such as Molecular Cell, Frontiers in Immunology and Biomedicine & Pharmacotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026